Abstract:Diabetes is one of the most prevalent cardiometabolic disorders on the planet. Type 1 diabetes accounts for only a minority of all cases (recently estimated to be ~2% globally); however, since this is a disorder with an early onset, many people live with type 1 diabetes for a long time. CVD and premature death are the main long-term outcomes for both types of diabetes; however, the type of diabetes that carries the highest risk of these outcomes is a controversial topic and has not been widely studied. Because of the association between diabetes and CVD, the rise in type 2 diabetes prevalence over the past decades has huge effects on global health. The excess risk in people with diabetes compared with those without depends, to a large extent, on the presence of other factors, such as general cardiovascular risk factors (e.g. elevated LDL-cholesterol, hypertension and smoking) and also factors that are more specific to diabetes (e.g. HbA1c, and micro- and macroalbuminuria). Some contributory factors are modifiable, while others are not, such as age, sex and type of diabetes. Older people with type 2 diabetes who have risk factors that are under control can achieve levels of CVD risk that are similar to that of the general population, while younger individuals with type 1 diabetes are mostly unable to achieve similar levels of risk, probably because of long and cumulative exposure to raised blood glucose levels. Despite reports of declining rates of CVD among people with type 1 and type 2 diabetes, rising rates of both types of diabetes lead to a continuing rise in the number of people with cardiometabolic disorders worldwide, offsetting the progress made in many countries. Comparison between individuals with type 1 and type 2 diabetes with respect to risk of CVD is fraught with difficulties and highly dependent on other, concomitant factors, some of which are modifiable and others not. Nonetheless, as a whole, what matters most in determining the management of diabetes is absolute risk and lifetime risk. Life-long efforts to achieve glycaemic control, control of lipids and hypertension, and not smoking are key to prevention, with a healthy lifestyle and pharmacological therapy to be implemented as needed.

The Influence of Different Types of Diabetes on Vascular Complications

Do Type 1 and Type 2 Diabetes Have the Same Vascular Complications?

Inflammatory Mechanisms of Diabetes and Its Vascular Complications

Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

The vascular complications of diabetes: a review of their management, pathogenesis, and prevention

Cardiovascular outcomes in type 1 and type 2 diabetes

The effect of Hyperglycemia and Oxidative Stress on the Development and Progress of Vascular Complications in Type 2 Diabetes

Diabetes and Vascular Disease: Is It All About Glycemia?

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank

Different types of cell death in diabetic endothelial dysfunction

Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses

Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions

Molecular Mechanisms and Clinical Insights

Exploration and identification of diabetes targets in nursing: CDH1 and DVL1

A review regarding the article 'Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project.'

Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy

Comparative study of endothelial function in different course of diabetic patients